Laurence Tam
Stock Analyst at Morgan Stanley
(0.90)
# 3,662
Out of 4,334 analysts
34
Total ratings
43.5%
Success rate
-4.7%
Average return
Main Sectors:
Stocks Rated by Laurence Tam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $50 | $32.72 | +52.81% | 5 | May 14, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Hold | $120 | $97.70 | +22.82% | 1 | Apr 15, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Maintained: Buy | $60 → $88 | $57.30 | +53.58% | 2 | Nov 21, 2025 | |
| HKG: 0570 China Traditional Chinese Medicine Holdings Co. Limited | Maintained: Sell | $1.6 | $1.60 | - | 7 | Oct 17, 2025 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Maintained: Buy | $25 → $23 | $17.55 | +28.21% | 4 | Aug 22, 2025 | |
| HKG: 3880 Medtide Inc. | Initiated Coverage: Hold | $38 | $22.32 | +70.25% | 1 | Aug 6, 2025 | |
| HKG: 0874 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Maintained: Hold | $22 → $21 | $15.83 | n/a | 4 | Dec 23, 2024 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Maintained: Buy | $18 → $17 | $11.73 | n/a | 3 | Dec 23, 2024 | |
| HKG: 3320 China Resources Pharmaceutical Group Limited | Maintained: Buy | $7.8 → $7.5 | $4.73 | n/a | 3 | Sep 17, 2024 | |
| HKG: 9989 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Maintained: Hold | $3.5 | $4.44 | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.1 | $3.67 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $15 | $7.14 | n/a | 2 | Mar 15, 2024 |
WuXi Biologics (Cayman) Inc.
May 14, 2026
Maintained: Buy
Price Target: $50
Current: $32.72
Upside: +52.81%
Asymchem Laboratories (Tianjin) Co., Ltd.
Apr 15, 2026
Maintained: Hold
Price Target: $120
Current: $97.70
Upside: +22.82%
WuXi XDC Cayman Inc.
Nov 21, 2025
Maintained: Buy
Price Target: $60 → $88
Current: $57.30
Upside: +53.58%
China Traditional Chinese Medicine Holdings Co. Limited
Oct 17, 2025
Maintained: Sell
Price Target: $1.6
Current: $1.60
Upside: -
Sinopharm Group Co. Ltd.
Aug 22, 2025
Maintained: Buy
Price Target: $25 → $23
Current: $17.55
Upside: +28.21%
Medtide Inc.
Aug 6, 2025
Initiated Coverage: Hold
Price Target: $38
Current: $22.32
Upside: +70.25%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Dec 23, 2024
Maintained: Hold
Price Target: $22 → $21
Current: $15.83
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Dec 23, 2024
Maintained: Buy
Price Target: $18 → $17
Current: $11.73
Upside: n/a
China Resources Pharmaceutical Group Limited
Sep 17, 2024
Maintained: Buy
Price Target: $7.8 → $7.5
Current: $4.73
Upside: n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Sep 17, 2024
Maintained: Hold
Price Target: $3.5
Current: $4.44
Upside: n/a
Apr 17, 2024
Maintained: Hold
Price Target: $6.1
Current: $3.67
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: $17 → $15
Current: $7.14
Upside: n/a